[ad_1]
BRAVE Fight Federation is about to ship certainly one of its most extremely anticipated rematches as top-ranked featherweight contender Omar Solomanov faces number-two ranked Rauan Bekbolat for the Interim Featherweight World Title at BRAVE CF 98 in China on September 19.
Their rivalry started at BRAVE CF 85 in Lahore, Pakistan, the place Solomanov entered undefeated in 11 skilled fights and on the point of a title shot. For the primary two rounds, the Ukrainian appeared dominant, controlling the tempo and showcasing his trademark precision. Nonetheless, in a surprising twist, Kazakh newcomer Bekbolat snatched a guillotine choke within the third spherical, rendering Solomanov unconscious and pulling off probably the most memorable upsets in BRAVE CF historical past.
Since that fateful night time, each fighters have made their mark. Solomanov bounced again in model with a first-round demolition of Izzedine Derbani at BRAVE CF 92, proving his aggressive, technical model stays harmful. Bekbolat, in the meantime, adopted up his upset victory with a brutal liver punch knockout over beforehand unbeaten Zequiodoji, cementing himself as a authentic contender.
With reigning champion Nemat Abdrashitov sidelined, the stakes have by no means been greater. For Solomanov, that is greater than a title battle—it’s his shot at redemption and erasing the lone blemish on his document. For Bekbolat, it’s the possibility to silence any doubters and show his first win was no fluke.
BRAVE CF 98 guarantees nothing in need of fireworks as two of the division’s finest collide as soon as once more. Will or not it’s redemption for Solomanov, or will Bekbolat repeat historical past and stroll out of China with gold round his waist?
Roberto Villa is the CEO, Founder, Government Author, Senior Editor of FightBook MMA. Has a ardour for Fight Sports activities and in addition a podcast host for Sitting Ringside. He’s additionally a former MMA fighter and Kickboxer.
Uncover extra from FightBook MMA
Subscribe to get the newest posts despatched to your e-mail.
Proceed Studying
[ad_2]
Source link
